A critical breakthrough in cancer investigation is emerging with the use of nanobodies to re-engage dysfunctional p53. This crucial cancer suppressor protein is frequently disabled in various forms of tumors, resulting https://madbookmarks.com/story21987622/vhh-fragments-reactivate-the-p53-protein-new-promising-pathway-for-cancer-management